IDI (ENXTPA:IDIP) and the management team of Prévost led by Marc-Henry Lussigny agreed to acquire 90% stake in Prévost Laboratory Concept from Abénex Capital SA and Arkéa Capital, SAS on July 6, 2023. The acquisition will be finalized in the coming weeks, subject to the fulfillment of the usual conditions precedent.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.8 EUR | +0.54% | 0.00% | +10.98% |
Apr. 09 | IDI: acquisition of a majority stake in Exsto | CF |
Apr. 08 | IDI acquired an unknown majority stake in EXSTO SAS. | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.98% | 569M | |
+3.65% | 31.94B | |
0.00% | 17.45B | |
+6.42% | 5.54B | |
-0.42% | 3.08B | |
+15.23% | 2.98B | |
+22.64% | 2.9B | |
-18.98% | 2.24B | |
+4.02% | 1.23B | |
-2.00% | 1.07B |
- Stock Market
- Equities
- IDIP Stock
- News IDI
- IDI and the management team of Prévost led by Marc-Henry Lussigny agreed to acquire 90% stake in Prévost Laboratory Concept from Abénex Capital SA and Arkéa Capital, SAS.